0001193125-26-168210
SEC filingProfit and profit margin declined in 2025, primarily due to higher net finance costs—including non-recurring refinancing expenses—partially offset by favorable foreign exchange effects and stable operating performance.
The decrease in profit and profit margin was primarily driven by higher net finance costs, including non-recurring refinancing costs incurred in 2025. This dynamic was partially offset by favorable foreign exchange effects and stable operating performance. Importantly, the underlying operational foundation remained resilient: service delivery, clinical coordination, and network scale continued to support consistent execution despite external financial headwinds.
We further expanded our presence in Colombia through the acquisition of Clínica Portoazul—a provider with state-of-the-art facilities and a premium customer portfolio located in Barranquilla, the country’s fourth-largest city. This move reinforces our regional footprint strategy and complements our existing infrastructure, which includes multiple owned facilities across key urban centers such as Lima and Chiclayo. Operational signals confirm active facility-level deployment, including Cantella (Lima), Auna Benavides (Lima), and Servimédicos (Chiclayo), each reflecting differentiated capacity and service configurations aligned with local demand.
Our vertically integrated approach enables us to cover all patients’ healthcare needs in a preventative and coordinated manner. This model directly enhances customer satisfaction and clinical outcomes—factors that drive positive brand awareness, greater customer loyalty, and increased demand for our services. The consistency of this value proposition strengthens our competitive positioning and underpins long-term revenue sustainability independent of short-term financial volatility.
As part of our integrated sales and marketing strategy, we focus on optimizing customer acquisition cost while offering a strong and proven portfolio. Solid financial growth continues to be backed by strong operating fundamentals, including the scale of our networks and disciplined cost efficiency. Management emphasizes that these attributes have enabled market-leading financial performance over time—even as discrete events like refinancing temporarily affect reported metrics.
Given the scope, complexity, and multi-year nature of certain remediation initiatives, management expects that remediation efforts will continue beyond 2026 and may extend into future reporting periods. Additionally, because our health plans are integrated into our horizontally integrated network, they provide patients with confidence in both the quality of care and cost predictability—reinforcing trust as a durable driver of retention and growth.